APTOSE BIOSCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.61 CAD | -1.23% |
|
-4.17% | -51.94% |
| May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APTOSE BIOSCIENCES INC. | Other Biotechnology & Medical Research | -1.23% | -4.17% | -51.94% | -83.49% | -96.17% | 19.3M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- APS Stock
- Charts Aptose Biosciences Inc.
- Comparison Chart
